Evidence map›Paper›PMID 36998578›Full record

ArticleReumatologia2023

Systemic sclerosis and rheumatoid arthritis overlap syndrome - management of severe cardiac, pulmonary and articular involvement.

Ana Sofia Pinto, Filipe Cunha Santos, Sara Paiva Dinis, Nathalie Madeira, Joana Fonseca Ferreira, Claúdia Vaz

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Reumatologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Sofia PintoDepartment of Rheumatology, Unidade Local de Saúde da Guarda, Portugal.ORCID https://orcid.org/0000-0002-4026-8357
Filipe Cunha SantosDepartment of Rheumatology, Unidade Local de Saúde da Guarda, Portugal.ORCID https://orcid.org/0000-0003-4714-0353
Sara Paiva DinisDepartment of Rheumatology, Unidade Local de Saúde da Guarda, Portugal.
Nathalie MadeiraDepartment of Rheumatology, Unidade Local de Saúde da Guarda, Portugal.
Joana Fonseca FerreiraDepartment of Rheumatology, Unidade Local de Saúde da Guarda, Portugal.ORCID https://orcid.org/0000-0003-2398-9029
Claúdia VazDepartment of Rheumatology, Unidade Local de Saúde da Guarda, Portugal.ORCID https://orcid.org/0000-0003-0745-3312
Instituto Politécnico da Guarda · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The presence of another rheumatological condition in patients with systemic sclerosis (SSc) is not uncommon. To report a case of a patient with SSc-RA overlap and perform a review of the cases reported in the literature. Material and methods: A chart review of the present case report was performed. After, we performed a literature search in MEDLINE, EMBASE and Cochrane databases. Results: We included 26 articles. Sixty-three patients were reviewed, 51 were female with a mean age of 45.03 years at the time of the first diagnosis. Sixty-three patients were diagnosed with limited cutaneous SSc. Regarding organ involvement, the most frequently reported were cutaneous, vascular, pulmonary and gastrointestinal involvement. Erosions were presenting 65.08% of patients. A panoply of treatments was used. Conclusions: The authors concluded that screening for an associated disease should be encouraged since the overlap with SSc may affect prognosis and treatment.

Indexed as

overlaprheumatoid arthritisrituximabsystematic reviewsystemic sclerosis

Identifiers

PMID36998578
PMCPMC10044038
OpenAlexW4323545060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.